Rhumbline Advisers Cerus Corp Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Cerus Corp stock. As of the latest transaction made, Rhumbline Advisers holds 230,337 shares of CERS stock, worth $363,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares
230,337
Previous 252,444 8.76%
Holding current value
$363,932
Previous $444,000 9.91%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$1.7 - $2.39 $37,581 - $52,835
-22,107 Reduced 8.76%
230,337 $400,000
Q2 2024

Aug 01, 2024
BUY
$1.62 - $2.04 $17,397 - $21,907
10,739 Added 4.44%
252,444 $444,000
Q1 2024

May 09, 2024
BUY
$1.66 - $2.42 $13,034 - $19,001
7,852 Added 3.36%
241,705 $456,000
Q4 2023

Feb 08, 2024
SELL
$1.25 - $2.35 $670 - $1,259
-536 Reduced 0.23%
233,853 $505,000
Q3 2023

Nov 09, 2023
SELL
$1.5 - $3.07 $1,227 - $2,511
-818 Reduced 0.35%
234,389 $379,000
Q2 2023

Aug 08, 2023
BUY
$1.79 - $2.9 $10,995 - $17,814
6,143 Added 2.68%
235,207 $578,000
Q1 2023

May 11, 2023
BUY
$2.65 - $3.81 $22,525 - $32,385
8,500 Added 3.85%
229,064 $680,000
Q4 2022

Feb 14, 2023
BUY
$3.38 - $4.22 $16,578 - $20,699
4,905 Added 2.27%
220,564 $805,000
Q3 2022

Nov 10, 2022
BUY
$3.43 - $5.83 $53,192 - $90,411
15,508 Added 7.75%
215,659 $776,000
Q2 2022

Aug 11, 2022
BUY
$4.41 - $5.69 $101,831 - $131,387
23,091 Added 13.04%
200,151 $1.06 Million
Q1 2022

May 12, 2022
SELL
$4.81 - $6.99 $92,655 - $134,648
-19,263 Reduced 9.81%
177,060 $972,000
Q4 2021

Feb 10, 2022
SELL
$5.97 - $7.93 $18,727 - $24,876
-3,137 Reduced 1.57%
196,323 $1.34 Million
Q3 2021

Nov 12, 2021
BUY
$4.79 - $6.68 $28,466 - $39,699
5,943 Added 3.07%
199,460 $1.22 Million
Q2 2021

Aug 05, 2021
SELL
$5.35 - $6.35 $74,910 - $88,912
-14,002 Reduced 6.75%
193,517 $1.14 Million
Q1 2021

May 06, 2021
SELL
$5.68 - $7.87 $67,364 - $93,338
-11,860 Reduced 5.41%
207,519 $1.25 Million
Q4 2020

Feb 10, 2021
BUY
$5.25 - $8.56 $28,339 - $46,206
5,398 Added 2.52%
219,379 $1.52 Million
Q3 2020

Nov 12, 2020
SELL
$5.78 - $7.47 $161,637 - $208,898
-27,965 Reduced 11.56%
213,981 $1.34 Million
Q2 2020

Aug 13, 2020
BUY
$4.5 - $7.02 $230,269 - $359,220
51,171 Added 26.82%
241,946 $1.6 Million
Q1 2020

May 06, 2020
BUY
$2.87 - $5.49 $13,179 - $25,210
4,592 Added 2.47%
190,775 $887,000
Q4 2019

Feb 05, 2020
BUY
$3.84 - $4.86 $6,716 - $8,500
1,749 Added 0.95%
186,183 $786,000
Q3 2019

Oct 23, 2019
BUY
$4.86 - $6.05 $9,933 - $12,366
2,044 Added 1.12%
184,434 $951,000
Q2 2019

Aug 14, 2019
BUY
$4.51 - $6.6 $29,003 - $42,444
6,431 Added 3.65%
182,390 $1.03 Million
Q1 2019

May 01, 2019
BUY
$5.16 - $6.85 $1,279 - $1,698
248 Added 0.14%
175,959 $1.1 Million
Q4 2018

Jan 31, 2019
BUY
$4.89 - $7.16 $280,553 - $410,790
57,373 Added 48.48%
175,711 $891,000
Q3 2018

Nov 07, 2018
SELL
$6.89 - $7.78 $44,612 - $50,375
-6,475 Reduced 5.19%
118,338 $853,000
Q2 2018

Aug 06, 2018
BUY
$5.19 - $7.25 $90,389 - $126,266
17,416 Added 16.22%
124,813 $833,000
Q1 2018

May 02, 2018
BUY
$3.56 - $5.74 $37,664 - $60,729
10,580 Added 10.93%
107,397 $589,000
Q4 2017

Feb 09, 2018
SELL
$2.76 - $3.95 $50,546 - $72,340
-18,314 Reduced 15.91%
96,817 $327,000
Q3 2017

Nov 06, 2017
BUY
$2.22 - $2.73 $255,590 - $314,307
115,131
115,131 $314,000

Others Institutions Holding CERS

# of Institutions
155
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $280M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email